OMX Nordic 40 2729754 / SE0001809476
2’629.08
Pkt
3.88
Pkt
0.15
%
17:35:09
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
| 21.09.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.09.26 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 21.09.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 17.09.26 | Novo Nordisk Neutral | UBS AG | |
| 16.09.26 | AstraZeneca Buy | UBS AG | |
| 16.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 16.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.09.26 | Novo Nordisk Sell | Deutsche Bank AG | |
| 15.09.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.09.26 | AstraZeneca Hold | Deutsche Bank AG | |
| 14.09.26 | Volvo AB Buy | Jefferies & Company Inc. | |
| 14.09.26 | ABB Market-Perform | Bernstein Research | |
| 14.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.09.26 | Volvo AB Market-Perform | Bernstein Research | |
| 14.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 11.09.26 | Novo Nordisk Underweight | Morgan Stanley | |
| 10.09.26 | Volvo AB Sector Perform | RBC Capital Markets | |
| 10.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 10.09.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.09.26 | AstraZeneca Outperform | RBC Capital Markets | |
| 08.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.09.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 08.09.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 03.09.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.09.26 | Novo Nordisk Sell | Deutsche Bank AG | |
| 02.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 01.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.08.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 27.08.26 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 27.08.26 | Novo Nordisk Sell | Deutsche Bank AG | |
| 26.08.26 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 25.08.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 25.08.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 25.08.26 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 25.08.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.08.26 | ABB Market-Perform | Bernstein Research | |
| 20.08.26 | AstraZeneca Buy | Goldman Sachs Group Inc. |